Clinic Observation of Alprostadil to Cure Diabetic Nephropathy
- VernacularTitle:前列地尔治疗糖尿病肾病临床研究
- Author:
Libo CHEN
;
Changning ZHANG
;
Haiyan ZHAO
- Publication Type:Journal Article
- Keywords:
Alprostadil;
Treatment;
Diabetic nephropathy
- From:
Journal of Medical Research
2006;0(06):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study on effects of Alprostadil on 24-hour urinary albumin(U-Alb)in patients with diabetic nephropathy.Methods:38 patients with diabetic nephropathy were included in the study.The test group involving 20 patients were grouped into group A(pristine diabetic nephropathy) and group B(clinical diabetic nephropathy)randomly according to urinary albumin.The control group including 18 patients were grouped into two groups according to the same way.The subjects in both groups have the same therapy in terms of control of blood glucose,blood pressure,plasma lipids,and other therapy methods.Besides,the test group was injected Alprostadil(凯时)10ug from vein,one time a day,14 day continuously,but Alprostadilas well.Results After the treatment of two groups,the level of the urinary albumin decreased obviously compared with the index before treathent,and decreased significantly compared with normal control group.Conclusion Alprostadil can lower urinary albumin with diabetic nephropathy.
